A
PAHC icon

AJOVista’s Phibro Animal Health PAHC Stock Holding History

AJOVista’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$287K Buy
+12,741
New +$246K 1.23% 12

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

AJOVista's PAHC Position: Q3 2024 in Review

AJOVista opened a new position in Phibro Animal Health (PAHC) in Q3 2024: 12,741 shares worth $287K. The stake represents 1.23% of the portfolio and ranks #12 among its holdings.

147 funds tracked by Wall St. Rank hold PAHC as of Q3 2024.

  • AJOVista held 12,741 shares of Phibro Animal Health worth $287K as of Q3 2024.
  • Phibro Animal Health was a new AJOVista position in Q3 2024.
  • Phibro Animal Health made up 1.23% of AJOVista's portfolio in Q3 2024, its #12 holding.
  • 147 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.